Rémi Pescarmona

1.1k citations
11 papers · 142 indexed · h-index 6
Topics
SARS-CoV-2 and COVID-19 Research (2 papers)Systemic Lupus Erythematosus Research (2 papers)COVID-19 Clinical Research Studies (2 papers)

In The Last Decade

Rémi Pescarmona

11 papers receiving 140 citations

Peers

Rémi Pescarmona
Comparison fields: 5 of 44
  • Immunology 57
  • Infectious Diseases 51
  • Molecular Biology 29
  • Rheumatology 25
  • Hematology 19
Replace Marine Villard with:
Marine Villard France
Lorien Shakib United States
Sue M. White Australia
Edith Schussler United States
Marta Español‐Rego Spain
Anabela Susana de Sousa Gonçalves Portugal
Sabrina Weeks United States
Krisztián Kállay Hungary
Zita Chovancová Czechia
Eva‐Maria Jacobsen Germany
Rémi Pescarmona relative to Marine Villard France Marine Villard's profile →
Citations per field
00.5×1.5×
Marine Villard · 1×
Citations per year

Countries citing papers authored by Rémi Pescarmona

Since Specialization
Citations

This map shows the geographic impact of Rémi Pescarmona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rémi Pescarmona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rémi Pescarmona more than expected).

Fields of papers citing papers by Rémi Pescarmona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rémi Pescarmona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rémi Pescarmona. The network helps show where Rémi Pescarmona may publish in the future.

Co-authorship network of co-authors of Rémi Pescarmona

This figure shows the co-authorship network connecting the top 25 collaborators of Rémi Pescarmona. A scholar is included among the top collaborators of Rémi Pescarmona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rémi Pescarmona. Rémi Pescarmona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 1
2 8
3 1
4 2
5 5
6 6
7 56
8 5
9 7
10 50
11 1

About Rémi Pescarmona

Rémi Pescarmona is a scholar working on Hematology, Immunology and Rheumatology, having authored 11 papers that have together received 142 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (2 papers), Systemic Lupus Erythematosus Research (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Infectious Diseases (51 citations), Immunology (57 citations) and Hematology (19 citations). Rémi Pescarmona has collaborated with scholars based in France, United States and Netherlands. Frequent co-authors include Alexandre Bélot, Thierry Walzer, Christine Lombard, Sébastien Viel, Sophie Trouillet‐Assant, Magali Perret, Marine Villard, Laurie Besson, Anne‐Laure Mathieu and David Gonçalves. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026